Carboxyamidotriazole Delivers Potent Anti-Angiogenic, Safe, and Durable Treatment For Neovascular Ocular Disease
Time: 3:30 pm
day: Day Two
Details:
- Carboxyamidotriazole has an extensive human safety profile after systemic administration
- Carboxyamidotriazole is a novel chemical entity for ocular disease
- Carboxyamidotriazole can be durably administered and is effective in multiple pre-clinical models of ocular neovascular disease
